Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yujin Hoshida

Showing results (171-180 of 263) with videos related to

Pageof 27
Sort By:
Gut|December 15, 2015
Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinomaVictoria Tovar, Helena Cornella, Agrin Moeini, et al.
Hepatology Communications|September 27, 2024
HCC spatial transcriptomic profiling reveals significant and potentially targetable cancer-endothelial interactionsChenyue Lu, Amaya Pankaj, Michael Raabe, et al.
Journal of Hepatology|May 8, 2016
Interleukin-15 receptor α on hepatic stellate cells regulates hepatic fibrogenesis in miceJingjing Jiao, Kohtaro Ooka, Holger Fey, et al.
Bioorganic & Medicinal Chemistry Letters|October 30, 2016
Novel substituted aminothiazoles as potent and selective anti-hepatocellular carcinoma agentsHuagang Lu, John Rogowskyj, Wenquan Yu, et al.
Journal of Hepatology|July 30, 2015
Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantationOriana Miltiadous, Daniela Sia, Yujin Hoshida, et al.
Experimental & Molecular Medicine|November 18, 2017
Integrin alpha 11 in the regulation of the myofibroblast phenotype: implications for fibrotic diseasesRuchi Bansal, Shigeki Nakagawa, Saleh Yazdani, et al.
Cell Reports|October 27, 2016
Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of HepatocytesEloi R Verrier, Che C Colpitts, Charlotte Bach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2012
Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenibAnja Lachenmayer, Clara Alsinet, Radoslav Savic, et al.
Cancer Research|September 3, 2009
Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinomaYujin Hoshida, Sebastian M B Nijman, Masahiro Kobayashi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2015
Clinicopathological indices to predict hepatocellular carcinoma molecular classificationPoh Seng Tan, Shigeki Nakagawa, Nicolas Goossens, et al.
Pageof 27

Showing results (171-180 of 263) with videos related to

Sort By:
Pageof 27
Gut|December 15, 2015
Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinomaVictoria Tovar, Helena Cornella, Agrin Moeini, et al.
Hepatology Communications|September 27, 2024
HCC spatial transcriptomic profiling reveals significant and potentially targetable cancer-endothelial interactionsChenyue Lu, Amaya Pankaj, Michael Raabe, et al.
Journal of Hepatology|May 8, 2016
Interleukin-15 receptor α on hepatic stellate cells regulates hepatic fibrogenesis in miceJingjing Jiao, Kohtaro Ooka, Holger Fey, et al.
Bioorganic & Medicinal Chemistry Letters|October 30, 2016
Novel substituted aminothiazoles as potent and selective anti-hepatocellular carcinoma agentsHuagang Lu, John Rogowskyj, Wenquan Yu, et al.
Journal of Hepatology|July 30, 2015
Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantationOriana Miltiadous, Daniela Sia, Yujin Hoshida, et al.
Experimental & Molecular Medicine|November 18, 2017
Integrin alpha 11 in the regulation of the myofibroblast phenotype: implications for fibrotic diseasesRuchi Bansal, Shigeki Nakagawa, Saleh Yazdani, et al.
Cell Reports|October 27, 2016
Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of HepatocytesEloi R Verrier, Che C Colpitts, Charlotte Bach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2012
Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenibAnja Lachenmayer, Clara Alsinet, Radoslav Savic, et al.
Cancer Research|September 3, 2009
Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinomaYujin Hoshida, Sebastian M B Nijman, Masahiro Kobayashi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2015
Clinicopathological indices to predict hepatocellular carcinoma molecular classificationPoh Seng Tan, Shigeki Nakagawa, Nicolas Goossens, et al.
Pageof 27